Ionis Pharmaceuticals (NASDAQ:IONS) Earnings Information
Ionis Pharmaceuticals last posted its earnings data on February 24th, 2021. The reported ($2.44) EPS for the quarter, missing analysts' consensus estimates of $0.24 by $2.68. The business earned $290 million during the quarter, compared to the consensus estimate of $265.93 million. Ionis Pharmaceuticals has generated $2.08 earnings per share over the last year and currently has a price-to-earnings ratio of 87.0. Ionis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.
Ionis Pharmaceuticals Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Ionis Pharmaceuticals (NASDAQ:IONS) Earnings Estimates
2021 EPS Consensus Estimate: ($0.86)
2022 EPS Consensus Estimate: ($0.80)
Ionis Pharmaceuticals (NASDAQ IONS) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)